A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.
K Henry, A Erice, C Tierney...
https://pubmed.ncbi.nlm.nih.gov/9833742